Tarsus Pharmaceuticals

TARS

NASDAQHealth Care

Income Statement

Total Revenue$182.95M

Gross Profit$170.13M

Operating Income$-120.57M

EBITDA$-105.85M

EBIT$-107.71M

Pre-tax Income$-64.36M

Net Income$-115.55M

Cash Equivalent$161.46M

Total Debt$61.27M

Book Value$247.37M

Book Value Per Share6.67

Return on Equity (ROE)-51.46%

Return on Assets (ROA)-30.65%

Return on Invested Capital (ROI)-38.99%

Net Profit Margin-63.16%

Current Ratio4.42

Quick Ratio4.21

Long-Term Debt / Equity0.32